학술논문
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant
Document Type
Article
Author
Source
In: Trials . (Trials, December 2023, 24(1))
Subject
Language
English
ISSN
17456215